Cutia Therapeutics wins marketing approval for Cu-40102 in Macau
Cutia Therapeutics said its Cu-40102 has received marketing approval from the Macao Pharmaceutical Administration Bureau.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.